nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—P-Glycoprotein Inhibitors—Crizotinib—lung cancer	0.432	1	CiPCiCtD
Amiodarone—CYP2A6—lung cancer	0.095	0.482	CbGaD
Amiodarone—CYP1A1—lung cancer	0.0666	0.338	CbGaD
Amiodarone—ABCB1—lung cancer	0.0354	0.18	CbGaD
Amiodarone—CYP1A1—Gefitinib—lung cancer	0.0136	0.0604	CbGbCtD
Amiodarone—CYP3A5—Gefitinib—lung cancer	0.00814	0.0362	CbGbCtD
Amiodarone—CYP1A1—Erlotinib—lung cancer	0.00802	0.0357	CbGbCtD
Amiodarone—CYP3A5—Teniposide—lung cancer	0.00789	0.0351	CbGbCtD
Amiodarone—CYP2C19—Gefitinib—lung cancer	0.00657	0.0292	CbGbCtD
Amiodarone—CYP2C19—Teniposide—lung cancer	0.00637	0.0283	CbGbCtD
Amiodarone—CYP3A7—Paclitaxel—lung cancer	0.00587	0.0261	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.00587	0.0261	CbGbCtD
Amiodarone—CYP3A7—Irinotecan—lung cancer	0.00579	0.0258	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.00579	0.0258	CbGbCtD
Amiodarone—ABCB1—Topotecan—lung cancer	0.00579	0.0258	CbGbCtD
Amiodarone—CYP2C9—Gefitinib—lung cancer	0.00546	0.0243	CbGbCtD
Amiodarone—ABCB1—Gefitinib—lung cancer	0.0053	0.0236	CbGbCtD
Amiodarone—CYP2C9—Teniposide—lung cancer	0.00529	0.0236	CbGbCtD
Amiodarone—CYP2D6—Gefitinib—lung cancer	0.00499	0.0222	CbGbCtD
Amiodarone—CYP3A5—Crizotinib—lung cancer	0.00499	0.0222	CbGbCtD
Amiodarone—CYP3A5—Erlotinib—lung cancer	0.00481	0.0214	CbGbCtD
Amiodarone—CYP2C8—Erlotinib—lung cancer	0.00463	0.0206	CbGbCtD
Amiodarone—CYP3A5—Paclitaxel—lung cancer	0.00441	0.0196	CbGbCtD
Amiodarone—CYP3A5—Irinotecan—lung cancer	0.00435	0.0193	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.00425	0.0189	CbGbCtD
Amiodarone—CYP3A7—Docetaxel—lung cancer	0.00425	0.0189	CbGbCtD
Amiodarone—CYP2C8—Paclitaxel—lung cancer	0.00424	0.0189	CbGbCtD
Amiodarone—ABCB1—Vinorelbine—lung cancer	0.00408	0.0182	CbGbCtD
Amiodarone—CYP2D6—Vinorelbine—lung cancer	0.00385	0.0171	CbGbCtD
Amiodarone—CYP1A2—Erlotinib—lung cancer	0.00358	0.0159	CbGbCtD
Amiodarone—CYP3A5—Etoposide—lung cancer	0.00348	0.0155	CbGbCtD
Amiodarone—CYP3A4—Topotecan—lung cancer	0.00347	0.0154	CbGbCtD
Amiodarone—CYP2C8—Etoposide—lung cancer	0.00335	0.0149	CbGbCtD
Amiodarone—ABCB1—Crizotinib—lung cancer	0.00325	0.0145	CbGbCtD
Amiodarone—CYP3A5—Docetaxel—lung cancer	0.00319	0.0142	CbGbCtD
Amiodarone—CYP3A4—Gefitinib—lung cancer	0.00317	0.0141	CbGbCtD
Amiodarone—ABCB1—Gemcitabine—lung cancer	0.00317	0.0141	CbGbCtD
Amiodarone—ABCB1—Erlotinib—lung cancer	0.00313	0.0139	CbGbCtD
Amiodarone—CYP3A4—Teniposide—lung cancer	0.00308	0.0137	CbGbCtD
Amiodarone—CYP2C9—Paclitaxel—lung cancer	0.00295	0.0131	CbGbCtD
Amiodarone—CYP2D6—Erlotinib—lung cancer	0.00295	0.0131	CbGbCtD
Amiodarone—ABCB1—Paclitaxel—lung cancer	0.00287	0.0128	CbGbCtD
Amiodarone—ABCB1—Irinotecan—lung cancer	0.00283	0.0126	CbGbCtD
Amiodarone—CYP1A2—Etoposide—lung cancer	0.00259	0.0115	CbGbCtD
Amiodarone—ABCB1—Vinblastine—lung cancer	0.00251	0.0112	CbGbCtD
Amiodarone—CYP3A4—Vinorelbine—lung cancer	0.00245	0.0109	CbGbCtD
Amiodarone—CYP2C9—Cisplatin—lung cancer	0.00238	0.0106	CbGbCtD
Amiodarone—CYP2D6—Vinblastine—lung cancer	0.00237	0.0105	CbGbCtD
Amiodarone—ABCB1—Cisplatin—lung cancer	0.00231	0.0103	CbGbCtD
Amiodarone—ABCB1—Etoposide—lung cancer	0.00227	0.0101	CbGbCtD
Amiodarone—ABCB1—Docetaxel—lung cancer	0.00207	0.00923	CbGbCtD
Amiodarone—CYP3A4—Crizotinib—lung cancer	0.00195	0.00866	CbGbCtD
Amiodarone—CYP3A4—Erlotinib—lung cancer	0.00188	0.00835	CbGbCtD
Amiodarone—CYP3A4—Paclitaxel—lung cancer	0.00172	0.00765	CbGbCtD
Amiodarone—CYP3A4—Irinotecan—lung cancer	0.00169	0.00754	CbGbCtD
Amiodarone—Lucanthone—TOP1—lung cancer	0.0016	0.897	CrCbGaD
Amiodarone—ABCB1—Doxorubicin—lung cancer	0.00155	0.00688	CbGbCtD
Amiodarone—CYP3A4—Vinblastine—lung cancer	0.00151	0.00671	CbGbCtD
Amiodarone—ABCB1—Methotrexate—lung cancer	0.0015	0.00666	CbGbCtD
Amiodarone—CYP2D6—Doxorubicin—lung cancer	0.00146	0.00648	CbGbCtD
Amiodarone—CYP3A4—Etoposide—lung cancer	0.00136	0.00604	CbGbCtD
Amiodarone—CYP3A4—Docetaxel—lung cancer	0.00124	0.00553	CbGbCtD
Amiodarone—CYP3A4—Doxorubicin—lung cancer	0.000926	0.00412	CbGbCtD
Amiodarone—THRB—mammary gland—lung cancer	0.00088	0.0939	CbGeAlD
Amiodarone—CACNA2D2—mammary gland—lung cancer	0.000871	0.0929	CbGeAlD
Amiodarone—CACNA2D2—respiratory system—lung cancer	0.00058	0.0619	CbGeAlD
Amiodarone—CACNA2D2—cardiac atrium—lung cancer	0.000403	0.043	CbGeAlD
Amiodarone—SIGMAR1—mammary gland—lung cancer	0.000403	0.043	CbGeAlD
Amiodarone—EBP—Azacitidine—Gemcitabine—lung cancer	0.000347	1	CbGdCrCtD
Amiodarone—THRB—lung—lung cancer	0.000311	0.0332	CbGeAlD
Amiodarone—THRA—lung—lung cancer	0.000311	0.0332	CbGeAlD
Amiodarone—CACNA2D2—lung—lung cancer	0.000308	0.0329	CbGeAlD
Amiodarone—CYP2C8—mammary gland—lung cancer	0.000293	0.0313	CbGeAlD
Amiodarone—CYP2C9—mammary gland—lung cancer	0.000261	0.0278	CbGeAlD
Amiodarone—ADRB1—bronchus—lung cancer	0.00023	0.0246	CbGeAlD
Amiodarone—SIGMAR1—bronchus—lung cancer	0.000221	0.0236	CbGeAlD
Amiodarone—THRA—lymph node—lung cancer	0.000213	0.0227	CbGeAlD
Amiodarone—THRB—lymph node—lung cancer	0.000213	0.0227	CbGeAlD
Amiodarone—CACNA2D2—lymph node—lung cancer	0.000211	0.0225	CbGeAlD
Amiodarone—SIGMAR1—trachea—lung cancer	0.000198	0.0212	CbGeAlD
Amiodarone—ADRB1—cardiac atrium—lung cancer	0.000194	0.0207	CbGeAlD
Amiodarone—SIGMAR1—cardiac atrium—lung cancer	0.000186	0.0199	CbGeAlD
Amiodarone—CYP2A6—lung—lung cancer	0.000185	0.0197	CbGeAlD
Amiodarone—CYP1A2—respiratory system—lung cancer	0.000183	0.0195	CbGeAlD
Amiodarone—CYP1A1—respiratory system—lung cancer	0.00018	0.0193	CbGeAlD
Amiodarone—CYP3A5—respiratory system—lung cancer	0.000176	0.0188	CbGeAlD
Amiodarone—CACNA1H—lymph node—lung cancer	0.000171	0.0182	CbGeAlD
Amiodarone—SIGMAR1—bone marrow—lung cancer	0.000157	0.0168	CbGeAlD
Amiodarone—CYP1A1—epithelium—lung cancer	0.000151	0.0161	CbGeAlD
Amiodarone—ADRB1—lung—lung cancer	0.000149	0.0159	CbGeAlD
Amiodarone—CYP1A1—bronchus—lung cancer	0.000148	0.0158	CbGeAlD
Amiodarone—KCNH2—cardiac atrium—lung cancer	0.000148	0.0158	CbGeAlD
Amiodarone—SIGMAR1—lung—lung cancer	0.000143	0.0152	CbGeAlD
Amiodarone—CYP1A1—trachea—lung cancer	0.000133	0.0142	CbGeAlD
Amiodarone—CYP1A1—cardiac atrium—lung cancer	0.000125	0.0134	CbGeAlD
Amiodarone—KCNH2—bone marrow—lung cancer	0.000125	0.0134	CbGeAlD
Amiodarone—SIGMAR1—lymph node—lung cancer	9.75e-05	0.0104	CbGeAlD
Amiodarone—CYP1A2—lung—lung cancer	9.71e-05	0.0104	CbGeAlD
Amiodarone—CYP1A1—lung—lung cancer	9.58e-05	0.0102	CbGeAlD
Amiodarone—Dronedarone—ALB—lung cancer	9.47e-05	0.0529	CrCbGaD
Amiodarone—ABCB1—respiratory system—lung cancer	9.37e-05	0.01	CbGeAlD
Amiodarone—CYP3A5—lung—lung cancer	9.37e-05	0.01	CbGeAlD
Amiodarone—Dronedarone—ABCB1—lung cancer	9.04e-05	0.0505	CrCbGaD
Amiodarone—ABCB1—epithelium—lung cancer	7.83e-05	0.00836	CbGeAlD
Amiodarone—KCNH2—lymph node—lung cancer	7.76e-05	0.00828	CbGeAlD
Amiodarone—ABCB1—trachea—lung cancer	6.93e-05	0.00739	CbGeAlD
Amiodarone—CYP1A1—lymph node—lung cancer	6.55e-05	0.00699	CbGeAlD
Amiodarone—ABCB1—bone marrow—lung cancer	5.49e-05	0.00586	CbGeAlD
Amiodarone—ABCB1—lung—lung cancer	4.98e-05	0.00531	CbGeAlD
Amiodarone—ABCB1—lymph node—lung cancer	3.4e-05	0.00363	CbGeAlD
Amiodarone—Thrombocytopenia—Paclitaxel—lung cancer	2.86e-05	0.000331	CcSEcCtD
Amiodarone—Tachycardia—Paclitaxel—lung cancer	2.85e-05	0.00033	CcSEcCtD
Amiodarone—Anorexia—Etoposide—lung cancer	2.84e-05	0.000329	CcSEcCtD
Amiodarone—Skin disorder—Paclitaxel—lung cancer	2.84e-05	0.000328	CcSEcCtD
Amiodarone—Body temperature increased—Irinotecan—lung cancer	2.83e-05	0.000328	CcSEcCtD
Amiodarone—Abdominal pain—Irinotecan—lung cancer	2.83e-05	0.000328	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Doxorubicin—lung cancer	2.83e-05	0.000328	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Doxorubicin—lung cancer	2.83e-05	0.000328	CcSEcCtD
Amiodarone—Decreased appetite—Cisplatin—lung cancer	2.83e-05	0.000327	CcSEcCtD
Amiodarone—Hyperhidrosis—Paclitaxel—lung cancer	2.83e-05	0.000327	CcSEcCtD
Amiodarone—Pneumonia—Methotrexate—lung cancer	2.82e-05	0.000326	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Cisplatin—lung cancer	2.81e-05	0.000325	CcSEcCtD
Amiodarone—Anorexia—Paclitaxel—lung cancer	2.79e-05	0.000322	CcSEcCtD
Amiodarone—Hypotension—Etoposide—lung cancer	2.79e-05	0.000322	CcSEcCtD
Amiodarone—Pain—Cisplatin—lung cancer	2.78e-05	0.000322	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Methotrexate—lung cancer	2.78e-05	0.000321	CcSEcCtD
Amiodarone—Muscular weakness—Doxorubicin—lung cancer	2.77e-05	0.000321	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Doxorubicin—lung cancer	2.77e-05	0.000321	CcSEcCtD
Amiodarone—Vomiting—Vinorelbine—lung cancer	2.76e-05	0.000319	CcSEcCtD
Amiodarone—Body temperature increased—Gemcitabine—lung cancer	2.76e-05	0.000319	CcSEcCtD
Amiodarone—Renal failure—Methotrexate—lung cancer	2.75e-05	0.000318	CcSEcCtD
Amiodarone—Rash—Vinorelbine—lung cancer	2.74e-05	0.000317	CcSEcCtD
Amiodarone—Dermatitis—Vinorelbine—lung cancer	2.74e-05	0.000316	CcSEcCtD
Amiodarone—Hypotension—Paclitaxel—lung cancer	2.73e-05	0.000316	CcSEcCtD
Amiodarone—Headache—Vinorelbine—lung cancer	2.72e-05	0.000315	CcSEcCtD
Amiodarone—Eosinophilia—Doxorubicin—lung cancer	2.69e-05	0.000311	CcSEcCtD
Amiodarone—Sweating—Methotrexate—lung cancer	2.68e-05	0.00031	CcSEcCtD
Amiodarone—Feeling abnormal—Cisplatin—lung cancer	2.68e-05	0.00031	CcSEcCtD
Amiodarone—Paraesthesia—Etoposide—lung cancer	2.68e-05	0.000309	CcSEcCtD
Amiodarone—Pancreatitis—Doxorubicin—lung cancer	2.67e-05	0.000308	CcSEcCtD
Amiodarone—Dyspnoea—Etoposide—lung cancer	2.66e-05	0.000307	CcSEcCtD
Amiodarone—Cough—Docetaxel—lung cancer	2.65e-05	0.000306	CcSEcCtD
Amiodarone—Angina pectoris—Doxorubicin—lung cancer	2.65e-05	0.000306	CcSEcCtD
Amiodarone—Insomnia—Paclitaxel—lung cancer	2.64e-05	0.000306	CcSEcCtD
Amiodarone—Hypersensitivity—Irinotecan—lung cancer	2.64e-05	0.000305	CcSEcCtD
Amiodarone—Paraesthesia—Paclitaxel—lung cancer	2.62e-05	0.000303	CcSEcCtD
Amiodarone—Agranulocytosis—Methotrexate—lung cancer	2.61e-05	0.000302	CcSEcCtD
Amiodarone—Dyspnoea—Paclitaxel—lung cancer	2.61e-05	0.000301	CcSEcCtD
Amiodarone—Decreased appetite—Etoposide—lung cancer	2.59e-05	0.0003	CcSEcCtD
Amiodarone—Pancytopenia—Doxorubicin—lung cancer	2.58e-05	0.000299	CcSEcCtD
Amiodarone—Nausea—Vinorelbine—lung cancer	2.58e-05	0.000298	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Etoposide—lung cancer	2.57e-05	0.000298	CcSEcCtD
Amiodarone—Dyspepsia—Paclitaxel—lung cancer	2.57e-05	0.000297	CcSEcCtD
Amiodarone—Body temperature increased—Cisplatin—lung cancer	2.57e-05	0.000297	CcSEcCtD
Amiodarone—Asthenia—Irinotecan—lung cancer	2.57e-05	0.000297	CcSEcCtD
Amiodarone—Fatigue—Etoposide—lung cancer	2.57e-05	0.000297	CcSEcCtD
Amiodarone—Constipation—Etoposide—lung cancer	2.55e-05	0.000295	CcSEcCtD
Amiodarone—Pain—Etoposide—lung cancer	2.55e-05	0.000295	CcSEcCtD
Amiodarone—Neutropenia—Doxorubicin—lung cancer	2.54e-05	0.000294	CcSEcCtD
Amiodarone—Decreased appetite—Paclitaxel—lung cancer	2.54e-05	0.000294	CcSEcCtD
Amiodarone—Dry mouth—Docetaxel—lung cancer	2.53e-05	0.000292	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Paclitaxel—lung cancer	2.52e-05	0.000292	CcSEcCtD
Amiodarone—Fatigue—Paclitaxel—lung cancer	2.52e-05	0.000291	CcSEcCtD
Amiodarone—Hepatitis—Methotrexate—lung cancer	2.51e-05	0.000291	CcSEcCtD
Amiodarone—Asthenia—Gemcitabine—lung cancer	2.5e-05	0.00029	CcSEcCtD
Amiodarone—Pain—Paclitaxel—lung cancer	2.5e-05	0.000289	CcSEcCtD
Amiodarone—Constipation—Paclitaxel—lung cancer	2.5e-05	0.000289	CcSEcCtD
Amiodarone—Confusional state—Docetaxel—lung cancer	2.5e-05	0.000289	CcSEcCtD
Amiodarone—Photosensitivity reaction—Doxorubicin—lung cancer	2.48e-05	0.000287	CcSEcCtD
Amiodarone—Oedema—Docetaxel—lung cancer	2.48e-05	0.000286	CcSEcCtD
Amiodarone—Anaphylactic shock—Docetaxel—lung cancer	2.48e-05	0.000286	CcSEcCtD
Amiodarone—Weight increased—Doxorubicin—lung cancer	2.47e-05	0.000286	CcSEcCtD
Amiodarone—Pruritus—Gemcitabine—lung cancer	2.47e-05	0.000286	CcSEcCtD
Amiodarone—Infection—Docetaxel—lung cancer	2.46e-05	0.000285	CcSEcCtD
Amiodarone—Weight decreased—Doxorubicin—lung cancer	2.46e-05	0.000284	CcSEcCtD
Amiodarone—Feeling abnormal—Etoposide—lung cancer	2.46e-05	0.000284	CcSEcCtD
Amiodarone—Diarrhoea—Irinotecan—lung cancer	2.45e-05	0.000283	CcSEcCtD
Amiodarone—Pneumonia—Doxorubicin—lung cancer	2.44e-05	0.000282	CcSEcCtD
Amiodarone—Gastrointestinal pain—Etoposide—lung cancer	2.44e-05	0.000282	CcSEcCtD
Amiodarone—Shock—Docetaxel—lung cancer	2.44e-05	0.000282	CcSEcCtD
Amiodarone—Thrombocytopenia—Docetaxel—lung cancer	2.43e-05	0.00028	CcSEcCtD
Amiodarone—Visual impairment—Methotrexate—lung cancer	2.42e-05	0.00028	CcSEcCtD
Amiodarone—Tachycardia—Docetaxel—lung cancer	2.42e-05	0.00028	CcSEcCtD
Amiodarone—Feeling abnormal—Paclitaxel—lung cancer	2.41e-05	0.000278	CcSEcCtD
Amiodarone—Skin disorder—Docetaxel—lung cancer	2.41e-05	0.000278	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Doxorubicin—lung cancer	2.4e-05	0.000278	CcSEcCtD
Amiodarone—Hypersensitivity—Cisplatin—lung cancer	2.4e-05	0.000277	CcSEcCtD
Amiodarone—Gastrointestinal pain—Paclitaxel—lung cancer	2.39e-05	0.000276	CcSEcCtD
Amiodarone—Diarrhoea—Gemcitabine—lung cancer	2.39e-05	0.000276	CcSEcCtD
Amiodarone—Renal failure—Doxorubicin—lung cancer	2.38e-05	0.000276	CcSEcCtD
Amiodarone—Erythema multiforme—Methotrexate—lung cancer	2.38e-05	0.000275	CcSEcCtD
Amiodarone—Neuropathy peripheral—Doxorubicin—lung cancer	2.38e-05	0.000275	CcSEcCtD
Amiodarone—Dizziness—Irinotecan—lung cancer	2.37e-05	0.000274	CcSEcCtD
Amiodarone—Urticaria—Etoposide—lung cancer	2.37e-05	0.000274	CcSEcCtD
Amiodarone—Jaundice—Doxorubicin—lung cancer	2.36e-05	0.000273	CcSEcCtD
Amiodarone—Anorexia—Docetaxel—lung cancer	2.36e-05	0.000273	CcSEcCtD
Amiodarone—Body temperature increased—Etoposide—lung cancer	2.36e-05	0.000272	CcSEcCtD
Amiodarone—Abdominal pain—Etoposide—lung cancer	2.36e-05	0.000272	CcSEcCtD
Amiodarone—Tinnitus—Methotrexate—lung cancer	2.34e-05	0.000271	CcSEcCtD
Amiodarone—Asthenia—Cisplatin—lung cancer	2.33e-05	0.00027	CcSEcCtD
Amiodarone—Sweating—Doxorubicin—lung cancer	2.32e-05	0.000269	CcSEcCtD
Amiodarone—Urticaria—Paclitaxel—lung cancer	2.32e-05	0.000268	CcSEcCtD
Amiodarone—Hypotension—Docetaxel—lung cancer	2.32e-05	0.000268	CcSEcCtD
Amiodarone—Body temperature increased—Paclitaxel—lung cancer	2.31e-05	0.000267	CcSEcCtD
Amiodarone—Abdominal pain—Paclitaxel—lung cancer	2.31e-05	0.000267	CcSEcCtD
Amiodarone—Vomiting—Irinotecan—lung cancer	2.28e-05	0.000263	CcSEcCtD
Amiodarone—Agranulocytosis—Doxorubicin—lung cancer	2.26e-05	0.000262	CcSEcCtD
Amiodarone—Rash—Irinotecan—lung cancer	2.26e-05	0.000261	CcSEcCtD
Amiodarone—Dermatitis—Irinotecan—lung cancer	2.26e-05	0.000261	CcSEcCtD
Amiodarone—Headache—Irinotecan—lung cancer	2.25e-05	0.00026	CcSEcCtD
Amiodarone—Insomnia—Docetaxel—lung cancer	2.24e-05	0.000259	CcSEcCtD
Amiodarone—Diarrhoea—Cisplatin—lung cancer	2.23e-05	0.000257	CcSEcCtD
Amiodarone—Paraesthesia—Docetaxel—lung cancer	2.22e-05	0.000257	CcSEcCtD
Amiodarone—Alopecia—Methotrexate—lung cancer	2.22e-05	0.000257	CcSEcCtD
Amiodarone—Vomiting—Gemcitabine—lung cancer	2.22e-05	0.000257	CcSEcCtD
Amiodarone—Bradycardia—Doxorubicin—lung cancer	2.22e-05	0.000256	CcSEcCtD
Amiodarone—Dyspnoea—Docetaxel—lung cancer	2.21e-05	0.000255	CcSEcCtD
Amiodarone—Rash—Gemcitabine—lung cancer	2.2e-05	0.000254	CcSEcCtD
Amiodarone—Dermatitis—Gemcitabine—lung cancer	2.2e-05	0.000254	CcSEcCtD
Amiodarone—Hypersensitivity—Etoposide—lung cancer	2.2e-05	0.000254	CcSEcCtD
Amiodarone—Erythema—Methotrexate—lung cancer	2.19e-05	0.000253	CcSEcCtD
Amiodarone—Headache—Gemcitabine—lung cancer	2.19e-05	0.000253	CcSEcCtD
Amiodarone—Dyspepsia—Docetaxel—lung cancer	2.18e-05	0.000252	CcSEcCtD
Amiodarone—Hepatitis—Doxorubicin—lung cancer	2.18e-05	0.000252	CcSEcCtD
Amiodarone—Decreased appetite—Docetaxel—lung cancer	2.15e-05	0.000249	CcSEcCtD
Amiodarone—Hypersensitivity—Paclitaxel—lung cancer	2.15e-05	0.000249	CcSEcCtD
Amiodarone—Dysgeusia—Methotrexate—lung cancer	2.14e-05	0.000248	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Docetaxel—lung cancer	2.14e-05	0.000247	CcSEcCtD
Amiodarone—Asthenia—Etoposide—lung cancer	2.14e-05	0.000247	CcSEcCtD
Amiodarone—Fatigue—Docetaxel—lung cancer	2.14e-05	0.000247	CcSEcCtD
Amiodarone—Nausea—Irinotecan—lung cancer	2.13e-05	0.000246	CcSEcCtD
Amiodarone—Pain—Docetaxel—lung cancer	2.12e-05	0.000245	CcSEcCtD
Amiodarone—Constipation—Docetaxel—lung cancer	2.12e-05	0.000245	CcSEcCtD
Amiodarone—Back pain—Methotrexate—lung cancer	2.12e-05	0.000245	CcSEcCtD
Amiodarone—Pruritus—Etoposide—lung cancer	2.11e-05	0.000244	CcSEcCtD
Amiodarone—Visual impairment—Doxorubicin—lung cancer	2.1e-05	0.000242	CcSEcCtD
Amiodarone—Asthenia—Paclitaxel—lung cancer	2.1e-05	0.000242	CcSEcCtD
Amiodarone—Nausea—Gemcitabine—lung cancer	2.07e-05	0.00024	CcSEcCtD
Amiodarone—Vomiting—Cisplatin—lung cancer	2.07e-05	0.000239	CcSEcCtD
Amiodarone—Pruritus—Paclitaxel—lung cancer	2.07e-05	0.000239	CcSEcCtD
Amiodarone—Vision blurred—Methotrexate—lung cancer	2.06e-05	0.000238	CcSEcCtD
Amiodarone—Erythema multiforme—Doxorubicin—lung cancer	2.06e-05	0.000238	CcSEcCtD
Amiodarone—Rash—Cisplatin—lung cancer	2.05e-05	0.000237	CcSEcCtD
Amiodarone—Dermatitis—Cisplatin—lung cancer	2.05e-05	0.000237	CcSEcCtD
Amiodarone—Feeling abnormal—Docetaxel—lung cancer	2.04e-05	0.000236	CcSEcCtD
Amiodarone—Diarrhoea—Etoposide—lung cancer	2.04e-05	0.000236	CcSEcCtD
Amiodarone—Ill-defined disorder—Methotrexate—lung cancer	2.03e-05	0.000235	CcSEcCtD
Amiodarone—Tinnitus—Doxorubicin—lung cancer	2.03e-05	0.000235	CcSEcCtD
Amiodarone—Gastrointestinal pain—Docetaxel—lung cancer	2.03e-05	0.000234	CcSEcCtD
Amiodarone—Flushing—Doxorubicin—lung cancer	2.02e-05	0.000234	CcSEcCtD
Amiodarone—Diarrhoea—Paclitaxel—lung cancer	2e-05	0.000231	CcSEcCtD
Amiodarone—Malaise—Methotrexate—lung cancer	1.97e-05	0.000228	CcSEcCtD
Amiodarone—Dizziness—Etoposide—lung cancer	1.97e-05	0.000228	CcSEcCtD
Amiodarone—Vertigo—Methotrexate—lung cancer	1.97e-05	0.000227	CcSEcCtD
Amiodarone—Abdominal pain—Docetaxel—lung cancer	1.96e-05	0.000226	CcSEcCtD
Amiodarone—Body temperature increased—Docetaxel—lung cancer	1.96e-05	0.000226	CcSEcCtD
Amiodarone—Arrhythmia—Doxorubicin—lung cancer	1.94e-05	0.000225	CcSEcCtD
Amiodarone—Dizziness—Paclitaxel—lung cancer	1.93e-05	0.000223	CcSEcCtD
Amiodarone—Nausea—Cisplatin—lung cancer	1.93e-05	0.000223	CcSEcCtD
Amiodarone—Alopecia—Doxorubicin—lung cancer	1.92e-05	0.000222	CcSEcCtD
Amiodarone—Cough—Methotrexate—lung cancer	1.91e-05	0.000221	CcSEcCtD
Amiodarone—Vomiting—Etoposide—lung cancer	1.9e-05	0.000219	CcSEcCtD
Amiodarone—Erythema—Doxorubicin—lung cancer	1.89e-05	0.000219	CcSEcCtD
Amiodarone—Rash—Etoposide—lung cancer	1.88e-05	0.000217	CcSEcCtD
Amiodarone—Dermatitis—Etoposide—lung cancer	1.88e-05	0.000217	CcSEcCtD
Amiodarone—Headache—Etoposide—lung cancer	1.87e-05	0.000216	CcSEcCtD
Amiodarone—Vomiting—Paclitaxel—lung cancer	1.86e-05	0.000215	CcSEcCtD
Amiodarone—Dysgeusia—Doxorubicin—lung cancer	1.86e-05	0.000214	CcSEcCtD
Amiodarone—Rash—Paclitaxel—lung cancer	1.84e-05	0.000213	CcSEcCtD
Amiodarone—Dermatitis—Paclitaxel—lung cancer	1.84e-05	0.000213	CcSEcCtD
Amiodarone—Discomfort—Methotrexate—lung cancer	1.84e-05	0.000213	CcSEcCtD
Amiodarone—Back pain—Doxorubicin—lung cancer	1.83e-05	0.000212	CcSEcCtD
Amiodarone—Headache—Paclitaxel—lung cancer	1.83e-05	0.000212	CcSEcCtD
Amiodarone—Hypersensitivity—Docetaxel—lung cancer	1.83e-05	0.000211	CcSEcCtD
Amiodarone—Confusional state—Methotrexate—lung cancer	1.8e-05	0.000208	CcSEcCtD
Amiodarone—Anaphylactic shock—Methotrexate—lung cancer	1.79e-05	0.000206	CcSEcCtD
Amiodarone—Vision blurred—Doxorubicin—lung cancer	1.79e-05	0.000206	CcSEcCtD
Amiodarone—Asthenia—Docetaxel—lung cancer	1.78e-05	0.000205	CcSEcCtD
Amiodarone—Infection—Methotrexate—lung cancer	1.77e-05	0.000205	CcSEcCtD
Amiodarone—Nausea—Etoposide—lung cancer	1.77e-05	0.000205	CcSEcCtD
Amiodarone—Ill-defined disorder—Doxorubicin—lung cancer	1.76e-05	0.000203	CcSEcCtD
Amiodarone—Pruritus—Docetaxel—lung cancer	1.75e-05	0.000203	CcSEcCtD
Amiodarone—Thrombocytopenia—Methotrexate—lung cancer	1.75e-05	0.000202	CcSEcCtD
Amiodarone—Agitation—Doxorubicin—lung cancer	1.74e-05	0.000201	CcSEcCtD
Amiodarone—Nausea—Paclitaxel—lung cancer	1.74e-05	0.000201	CcSEcCtD
Amiodarone—Skin disorder—Methotrexate—lung cancer	1.73e-05	0.000201	CcSEcCtD
Amiodarone—Hyperhidrosis—Methotrexate—lung cancer	1.73e-05	0.0002	CcSEcCtD
Amiodarone—Malaise—Doxorubicin—lung cancer	1.71e-05	0.000198	CcSEcCtD
Amiodarone—Vertigo—Doxorubicin—lung cancer	1.7e-05	0.000197	CcSEcCtD
Amiodarone—Anorexia—Methotrexate—lung cancer	1.7e-05	0.000197	CcSEcCtD
Amiodarone—Diarrhoea—Docetaxel—lung cancer	1.7e-05	0.000196	CcSEcCtD
Amiodarone—Hypotension—Methotrexate—lung cancer	1.67e-05	0.000193	CcSEcCtD
Amiodarone—Cough—Doxorubicin—lung cancer	1.65e-05	0.000191	CcSEcCtD
Amiodarone—Dizziness—Docetaxel—lung cancer	1.64e-05	0.000189	CcSEcCtD
Amiodarone—Insomnia—Methotrexate—lung cancer	1.62e-05	0.000187	CcSEcCtD
Amiodarone—Anxiety—Doxorubicin—lung cancer	1.61e-05	0.000186	CcSEcCtD
Amiodarone—Paraesthesia—Methotrexate—lung cancer	1.6e-05	0.000185	CcSEcCtD
Amiodarone—Discomfort—Doxorubicin—lung cancer	1.59e-05	0.000184	CcSEcCtD
Amiodarone—Dyspnoea—Methotrexate—lung cancer	1.59e-05	0.000184	CcSEcCtD
Amiodarone—Dry mouth—Doxorubicin—lung cancer	1.58e-05	0.000182	CcSEcCtD
Amiodarone—Vomiting—Docetaxel—lung cancer	1.58e-05	0.000182	CcSEcCtD
Amiodarone—Dyspepsia—Methotrexate—lung cancer	1.57e-05	0.000182	CcSEcCtD
Amiodarone—Rash—Docetaxel—lung cancer	1.56e-05	0.000181	CcSEcCtD
Amiodarone—Dermatitis—Docetaxel—lung cancer	1.56e-05	0.00018	CcSEcCtD
Amiodarone—Confusional state—Doxorubicin—lung cancer	1.56e-05	0.00018	CcSEcCtD
Amiodarone—Decreased appetite—Methotrexate—lung cancer	1.55e-05	0.000179	CcSEcCtD
Amiodarone—Headache—Docetaxel—lung cancer	1.55e-05	0.000179	CcSEcCtD
Amiodarone—Anaphylactic shock—Doxorubicin—lung cancer	1.55e-05	0.000179	CcSEcCtD
Amiodarone—Oedema—Doxorubicin—lung cancer	1.55e-05	0.000179	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Methotrexate—lung cancer	1.54e-05	0.000178	CcSEcCtD
Amiodarone—Fatigue—Methotrexate—lung cancer	1.54e-05	0.000178	CcSEcCtD
Amiodarone—Infection—Doxorubicin—lung cancer	1.54e-05	0.000178	CcSEcCtD
Amiodarone—Pain—Methotrexate—lung cancer	1.53e-05	0.000177	CcSEcCtD
Amiodarone—Shock—Doxorubicin—lung cancer	1.52e-05	0.000176	CcSEcCtD
Amiodarone—Thrombocytopenia—Doxorubicin—lung cancer	1.51e-05	0.000175	CcSEcCtD
Amiodarone—Tachycardia—Doxorubicin—lung cancer	1.51e-05	0.000174	CcSEcCtD
Amiodarone—Skin disorder—Doxorubicin—lung cancer	1.5e-05	0.000174	CcSEcCtD
Amiodarone—Hyperhidrosis—Doxorubicin—lung cancer	1.49e-05	0.000173	CcSEcCtD
Amiodarone—Anorexia—Doxorubicin—lung cancer	1.47e-05	0.00017	CcSEcCtD
Amiodarone—Nausea—Docetaxel—lung cancer	1.47e-05	0.00017	CcSEcCtD
Amiodarone—Feeling abnormal—Methotrexate—lung cancer	1.47e-05	0.00017	CcSEcCtD
Amiodarone—Gastrointestinal pain—Methotrexate—lung cancer	1.46e-05	0.000169	CcSEcCtD
Amiodarone—Hypotension—Doxorubicin—lung cancer	1.44e-05	0.000167	CcSEcCtD
Amiodarone—Urticaria—Methotrexate—lung cancer	1.42e-05	0.000164	CcSEcCtD
Amiodarone—Abdominal pain—Methotrexate—lung cancer	1.41e-05	0.000163	CcSEcCtD
Amiodarone—Body temperature increased—Methotrexate—lung cancer	1.41e-05	0.000163	CcSEcCtD
Amiodarone—Insomnia—Doxorubicin—lung cancer	1.4e-05	0.000162	CcSEcCtD
Amiodarone—Paraesthesia—Doxorubicin—lung cancer	1.39e-05	0.000161	CcSEcCtD
Amiodarone—Dyspnoea—Doxorubicin—lung cancer	1.38e-05	0.000159	CcSEcCtD
Amiodarone—Dyspepsia—Doxorubicin—lung cancer	1.36e-05	0.000157	CcSEcCtD
Amiodarone—Decreased appetite—Doxorubicin—lung cancer	1.34e-05	0.000155	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Doxorubicin—lung cancer	1.33e-05	0.000154	CcSEcCtD
Amiodarone—Fatigue—Doxorubicin—lung cancer	1.33e-05	0.000154	CcSEcCtD
Amiodarone—Pain—Doxorubicin—lung cancer	1.32e-05	0.000153	CcSEcCtD
Amiodarone—Constipation—Doxorubicin—lung cancer	1.32e-05	0.000153	CcSEcCtD
Amiodarone—Hypersensitivity—Methotrexate—lung cancer	1.32e-05	0.000152	CcSEcCtD
Amiodarone—Asthenia—Methotrexate—lung cancer	1.28e-05	0.000148	CcSEcCtD
Amiodarone—Feeling abnormal—Doxorubicin—lung cancer	1.27e-05	0.000147	CcSEcCtD
Amiodarone—Gastrointestinal pain—Doxorubicin—lung cancer	1.26e-05	0.000146	CcSEcCtD
Amiodarone—Pruritus—Methotrexate—lung cancer	1.26e-05	0.000146	CcSEcCtD
Amiodarone—Urticaria—Doxorubicin—lung cancer	1.23e-05	0.000142	CcSEcCtD
Amiodarone—Body temperature increased—Doxorubicin—lung cancer	1.22e-05	0.000141	CcSEcCtD
Amiodarone—Abdominal pain—Doxorubicin—lung cancer	1.22e-05	0.000141	CcSEcCtD
Amiodarone—Diarrhoea—Methotrexate—lung cancer	1.22e-05	0.000141	CcSEcCtD
Amiodarone—Dizziness—Methotrexate—lung cancer	1.18e-05	0.000137	CcSEcCtD
Amiodarone—Hypersensitivity—Doxorubicin—lung cancer	1.14e-05	0.000132	CcSEcCtD
Amiodarone—Vomiting—Methotrexate—lung cancer	1.14e-05	0.000131	CcSEcCtD
Amiodarone—Rash—Methotrexate—lung cancer	1.13e-05	0.00013	CcSEcCtD
Amiodarone—Dermatitis—Methotrexate—lung cancer	1.12e-05	0.00013	CcSEcCtD
Amiodarone—Headache—Methotrexate—lung cancer	1.12e-05	0.000129	CcSEcCtD
Amiodarone—Asthenia—Doxorubicin—lung cancer	1.11e-05	0.000128	CcSEcCtD
Amiodarone—Pruritus—Doxorubicin—lung cancer	1.09e-05	0.000126	CcSEcCtD
Amiodarone—Nausea—Methotrexate—lung cancer	1.06e-05	0.000123	CcSEcCtD
Amiodarone—Diarrhoea—Doxorubicin—lung cancer	1.06e-05	0.000122	CcSEcCtD
Amiodarone—Dizziness—Doxorubicin—lung cancer	1.02e-05	0.000118	CcSEcCtD
Amiodarone—Vomiting—Doxorubicin—lung cancer	9.83e-06	0.000114	CcSEcCtD
Amiodarone—Rash—Doxorubicin—lung cancer	9.75e-06	0.000113	CcSEcCtD
Amiodarone—Dermatitis—Doxorubicin—lung cancer	9.74e-06	0.000113	CcSEcCtD
Amiodarone—Headache—Doxorubicin—lung cancer	9.69e-06	0.000112	CcSEcCtD
Amiodarone—Nausea—Doxorubicin—lung cancer	9.18e-06	0.000106	CcSEcCtD
Amiodarone—ADRB1—Signaling Pathways—EGF—lung cancer	1.74e-06	3.59e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ERCC2—lung cancer	1.74e-06	3.58e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—STK11—lung cancer	1.73e-06	3.58e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ENO1—lung cancer	1.73e-06	3.57e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—UGT1A1—lung cancer	1.73e-06	3.57e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.73e-06	3.56e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—TYMS—lung cancer	1.71e-06	3.53e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CREBBP—lung cancer	1.71e-06	3.52e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.7e-06	3.51e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GSTM1—lung cancer	1.69e-06	3.49e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—MAPK3—lung cancer	1.69e-06	3.48e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—POMC—lung cancer	1.68e-06	3.46e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.67e-06	3.44e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GNG11—lung cancer	1.67e-06	3.44e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—BRAF—lung cancer	1.66e-06	3.41e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTP1—lung cancer	1.64e-06	3.39e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL6R—lung cancer	1.64e-06	3.37e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—STK11—lung cancer	1.63e-06	3.37e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CREBBP—lung cancer	1.63e-06	3.37e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—STK11—lung cancer	1.62e-06	3.34e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CD—lung cancer	1.62e-06	3.34e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTP1—lung cancer	1.6e-06	3.31e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CYP1A1—lung cancer	1.6e-06	3.31e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—EGFR—lung cancer	1.6e-06	3.31e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CAT—lung cancer	1.6e-06	3.3e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ALB—lung cancer	1.6e-06	3.29e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ERCC2—lung cancer	1.59e-06	3.28e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.59e-06	3.28e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—APOA1—lung cancer	1.59e-06	3.28e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALDOA—lung cancer	1.59e-06	3.28e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CAT—lung cancer	1.56e-06	3.22e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MAP2K1—lung cancer	1.56e-06	3.21e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ABCB1—lung cancer	1.56e-06	3.21e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP2E1—lung cancer	1.55e-06	3.2e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CD—lung cancer	1.55e-06	3.19e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NCOA3—lung cancer	1.54e-06	3.18e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CB—lung cancer	1.54e-06	3.17e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NQO1—lung cancer	1.54e-06	3.17e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—PIK3CA—lung cancer	1.53e-06	3.16e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—TYMS—lung cancer	1.53e-06	3.15e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTGS2—lung cancer	1.52e-06	3.14e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.52e-06	3.14e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—KRAS—lung cancer	1.52e-06	3.13e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTP1—lung cancer	1.51e-06	3.12e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTM1—lung cancer	1.51e-06	3.12e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.5e-06	3.1e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—APOA1—lung cancer	1.5e-06	3.1e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ADCY1—lung cancer	1.5e-06	3.09e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ABCG2—lung cancer	1.5e-06	3.09e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTP1—lung cancer	1.5e-06	3.09e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—TYMS—lung cancer	1.49e-06	3.08e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.49e-06	3.07e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTM1—lung cancer	1.47e-06	3.04e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CAT—lung cancer	1.47e-06	3.03e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—HPGDS—lung cancer	1.47e-06	3.03e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ENO2—lung cancer	1.47e-06	3.03e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.46e-06	3.01e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CAT—lung cancer	1.46e-06	3.01e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CG—lung cancer	1.45e-06	2.99e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.45e-06	2.99e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.44e-06	2.97e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CYP1A1—lung cancer	1.43e-06	2.95e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ABCB1—lung cancer	1.43e-06	2.95e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTT1—lung cancer	1.43e-06	2.94e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ERCC2—lung cancer	1.42e-06	2.93e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ABCB1—lung cancer	1.42e-06	2.93e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CB—lung cancer	1.41e-06	2.91e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GCLC—lung cancer	1.41e-06	2.91e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP2A6—lung cancer	1.41e-06	2.91e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—TYMS—lung cancer	1.41e-06	2.9e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP1A1—lung cancer	1.4e-06	2.88e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTGS2—lung cancer	1.4e-06	2.88e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—TYMS—lung cancer	1.39e-06	2.87e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PIK3CA—lung cancer	1.39e-06	2.87e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTM1—lung cancer	1.39e-06	2.87e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MDM2—lung cancer	1.39e-06	2.86e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ERCC2—lung cancer	1.39e-06	2.86e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—STK11—lung cancer	1.38e-06	2.86e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—RAF1—lung cancer	1.38e-06	2.85e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—POMC—lung cancer	1.38e-06	2.85e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTM1—lung cancer	1.38e-06	2.84e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—APOA1—lung cancer	1.38e-06	2.84e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CG—lung cancer	1.37e-06	2.83e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ERBB2—lung cancer	1.37e-06	2.82e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MTOR—lung cancer	1.35e-06	2.78e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CB—lung cancer	1.35e-06	2.78e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CREBBP—lung cancer	1.35e-06	2.77e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ENO1—lung cancer	1.34e-06	2.76e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTEN—lung cancer	1.33e-06	2.74e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.32e-06	2.72e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP1A1—lung cancer	1.32e-06	2.72e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ERCC2—lung cancer	1.31e-06	2.69e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP1A1—lung cancer	1.31e-06	2.69e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—POMC—lung cancer	1.3e-06	2.69e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.3e-06	2.68e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CXCL8—lung cancer	1.3e-06	2.67e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ERCC2—lung cancer	1.3e-06	2.67e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—HRAS—lung cancer	1.29e-06	2.66e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTP1—lung cancer	1.28e-06	2.64e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CD—lung cancer	1.28e-06	2.63e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CREBBP—lung cancer	1.27e-06	2.62e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—EP300—lung cancer	1.27e-06	2.61e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ALB—lung cancer	1.26e-06	2.6e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CG—lung cancer	1.26e-06	2.59e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AKT1—lung cancer	1.25e-06	2.58e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CAT—lung cancer	1.25e-06	2.57e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CASP3—lung cancer	1.24e-06	2.56e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.24e-06	2.56e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL2—lung cancer	1.24e-06	2.56e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL6—lung cancer	1.23e-06	2.54e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—APOA1—lung cancer	1.23e-06	2.53e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTEN—lung cancer	1.22e-06	2.51e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ABCB1—lung cancer	1.21e-06	2.5e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCND1—lung cancer	1.21e-06	2.49e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—JUN—lung cancer	1.21e-06	2.49e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CD—lung cancer	1.21e-06	2.49e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—APOA1—lung cancer	1.2e-06	2.47e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP2E1—lung cancer	1.2e-06	2.47e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—POMC—lung cancer	1.2e-06	2.47e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—TYMS—lung cancer	1.19e-06	2.46e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ALB—lung cancer	1.19e-06	2.45e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NQO1—lung cancer	1.19e-06	2.44e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTM1—lung cancer	1.18e-06	2.43e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.18e-06	2.43e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MMP9—lung cancer	1.17e-06	2.42e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDKN1A—lung cancer	1.17e-06	2.41e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTEN—lung cancer	1.17e-06	2.41e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CREBBP—lung cancer	1.17e-06	2.4e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—EP300—lung cancer	1.16e-06	2.4e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AKT1—lung cancer	1.14e-06	2.35e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—APOA1—lung cancer	1.13e-06	2.33e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CG—lung cancer	1.12e-06	2.31e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—APOA1—lung cancer	1.12e-06	2.31e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP1A1—lung cancer	1.12e-06	2.3e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EP300—lung cancer	1.11e-06	2.29e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CB—lung cancer	1.11e-06	2.29e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ERCC2—lung cancer	1.11e-06	2.28e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CD—lung cancer	1.1e-06	2.28e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTGS2—lung cancer	1.1e-06	2.27e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CG—lung cancer	1.09e-06	2.26e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ALB—lung cancer	1.09e-06	2.25e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SRC—lung cancer	1.08e-06	2.23e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.07e-06	2.21e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—STK11—lung cancer	1.07e-06	2.2e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—POMC—lung cancer	1.07e-06	2.2e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VEGFA—lung cancer	1.05e-06	2.17e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CB—lung cancer	1.05e-06	2.17e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—STAT3—lung cancer	1.04e-06	2.15e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—POMC—lung cancer	1.04e-06	2.15e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTGS2—lung cancer	1.04e-06	2.15e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NRAS—lung cancer	1.04e-06	2.15e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CREBBP—lung cancer	1.04e-06	2.15e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CG—lung cancer	1.03e-06	2.13e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CG—lung cancer	1.02e-06	2.11e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CREBBP—lung cancer	1.02e-06	2.09e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MAPK3—lung cancer	9.96e-07	2.06e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTP1—lung cancer	9.89e-07	2.04e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CD—lung cancer	9.86e-07	2.03e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—POMC—lung cancer	9.82e-07	2.03e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—POMC—lung cancer	9.74e-07	2.01e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ALB—lung cancer	9.73e-07	2.01e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MYC—lung cancer	9.69e-07	2e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CB—lung cancer	9.63e-07	1.99e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CD—lung cancer	9.62e-07	1.99e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CAT—lung cancer	9.62e-07	1.98e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTEN—lung cancer	9.61e-07	1.98e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—APOA1—lung cancer	9.57e-07	1.97e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CREBBP—lung cancer	9.57e-07	1.97e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTGS2—lung cancer	9.54e-07	1.97e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ALB—lung cancer	9.5e-07	1.96e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CREBBP—lung cancer	9.48e-07	1.96e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EGFR—lung cancer	9.48e-07	1.96e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CA—lung cancer	9.38e-07	1.93e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ABCB1—lung cancer	9.36e-07	1.93e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TYMS—lung cancer	9.19e-07	1.9e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.17e-07	1.89e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—EP300—lung cancer	9.16e-07	1.89e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTM1—lung cancer	9.08e-07	1.87e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTEN—lung cancer	9.08e-07	1.87e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CD—lung cancer	9.07e-07	1.87e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CD—lung cancer	8.99e-07	1.85e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KRAS—lung cancer	8.95e-07	1.85e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ALB—lung cancer	8.95e-07	1.85e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ALB—lung cancer	8.88e-07	1.83e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CG—lung cancer	8.74e-07	1.8e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—EP300—lung cancer	8.66e-07	1.79e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP1A1—lung cancer	8.61e-07	1.78e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CB—lung cancer	8.6e-07	1.77e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CA—lung cancer	8.59e-07	1.77e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ERCC2—lung cancer	8.54e-07	1.76e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTGS2—lung cancer	8.52e-07	1.76e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CB—lung cancer	8.39e-07	1.73e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTEN—lung cancer	8.32e-07	1.72e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—POMC—lung cancer	8.32e-07	1.72e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTGS2—lung cancer	8.31e-07	1.71e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CA—lung cancer	8.23e-07	1.7e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CREBBP—lung cancer	8.1e-07	1.67e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—lung cancer	7.96e-07	1.64e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—EP300—lung cancer	7.94e-07	1.64e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CB—lung cancer	7.91e-07	1.63e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CB—lung cancer	7.84e-07	1.62e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTGS2—lung cancer	7.83e-07	1.62e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTGS2—lung cancer	7.77e-07	1.6e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CD—lung cancer	7.68e-07	1.58e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—AKT1—lung cancer	7.66e-07	1.58e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HRAS—lung cancer	7.61e-07	1.57e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ALB—lung cancer	7.58e-07	1.56e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTEN—lung cancer	7.43e-07	1.53e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—APOA1—lung cancer	7.39e-07	1.52e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL6—lung cancer	7.28e-07	1.5e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTEN—lung cancer	7.25e-07	1.5e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—EP300—lung cancer	7.08e-07	1.46e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—AKT1—lung cancer	7.02e-07	1.45e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—EP300—lung cancer	6.91e-07	1.43e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTEN—lung cancer	6.83e-07	1.41e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CA—lung cancer	6.78e-07	1.4e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTEN—lung cancer	6.77e-07	1.4e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CG—lung cancer	6.75e-07	1.39e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AKT1—lung cancer	6.72e-07	1.39e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CB—lung cancer	6.7e-07	1.38e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTGS2—lung cancer	6.64e-07	1.37e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—EP300—lung cancer	6.51e-07	1.34e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—EP300—lung cancer	6.46e-07	1.33e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—POMC—lung cancer	6.42e-07	1.32e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CA—lung cancer	6.4e-07	1.32e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CREBBP—lung cancer	6.25e-07	1.29e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CD—lung cancer	5.93e-07	1.22e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CA—lung cancer	5.87e-07	1.21e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALB—lung cancer	5.85e-07	1.21e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTEN—lung cancer	5.79e-07	1.19e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AKT1—lung cancer	5.54e-07	1.14e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—EP300—lung cancer	5.52e-07	1.14e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CA—lung cancer	5.24e-07	1.08e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AKT1—lung cancer	5.23e-07	1.08e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CB—lung cancer	5.17e-07	1.07e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTGS2—lung cancer	5.12e-07	1.06e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CA—lung cancer	5.11e-07	1.05e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CA—lung cancer	4.82e-07	9.94e-06	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AKT1—lung cancer	4.8e-07	9.89e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CA—lung cancer	4.78e-07	9.86e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTEN—lung cancer	4.47e-07	9.21e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AKT1—lung cancer	4.28e-07	8.83e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—EP300—lung cancer	4.26e-07	8.79e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AKT1—lung cancer	4.18e-07	8.62e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CA—lung cancer	4.08e-07	8.42e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AKT1—lung cancer	3.94e-07	8.12e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AKT1—lung cancer	3.9e-07	8.05e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AKT1—lung cancer	3.34e-07	6.88e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CA—lung cancer	3.15e-07	6.5e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AKT1—lung cancer	2.57e-07	5.31e-06	CbGpPWpGaD
